OMIA:002359-9823 : Resistance/susceptibility to classical swine fever virus (CSFV) in Sus scrofa (pig)
Categories: Immune system phene
Possibly relevant human trait(s) and/or gene(s) (MIM number): 607810 (gene)
Links to MONDO diseases: No links.
Mendelian trait/disorder: unknown
Considered a defect: yes
Species-specific description: Xie et al. (2028): "antiviral small hairpin RNAs (shRNAs) were selected and then inserted at the porcine Rosa26 (pRosa26) locus via a CRISPR/Cas9-mediated knock-in strategy. Finally, anti-CSFV transgenic (TG) pigs were produced by somatic nuclear transfer (SCNT). Notably, in vitro and in vivo viral challenge assays further demonstrated that these TG pigs could effectively limit the replication of CSFV and reduce CSFV-associated clinical signs and mortality, and disease resistance could be stably transmitted to the F1-generation."
Xie et al. (2020): "The RSAD2 exhibits antiviral activity against various DNA and RNA viruses. In this study, we successfully accomplished site-specific insertion of the porcine RSAD2 gene (pRSAD2) at the porcine ROSA26 (pROSA26) locus, generating pRSAD2 gene knock-in (pRSAD2-KI) PK-15 cells and porcine foetal fibroblasts (PFFs) via CRISPR/Cas9 technology. ... More importantly, we ultimately successfully produced a pRSAD2-KI pig that constitutively overexpressed the pRSAD2, viral challenge results indicated that fibroblasts isolated from the pRSAD2-KI pig reduced CSFV infection." These studies used genetically modified organisms (GMO).
Have human generated variants been created, e.g. through genetic engineering and gene editing
|Symbol||Description||Species||Chr||Location||OMIA gene details page||Other Links|
|RSAD2||radical S-adenosyl methionine domain containing 2||Sus scrofa||3||NC_010445.4 (128897809..128880853)||RSAD2||Homologene, Ensembl , NCBI gene|
Cite this entry
Note: the references are listed in reverse chronological order (from the most recent year to the earliest year), and alphabetically by first author within a year.
|2022||Mehrotra, A., Bhushan, B., Kumar, A., Panigrahi, M., A, K., Singh, A., Tiwari, A.K., Pausch, H., Dutt, T., Mishra, B.P. :|
|A 1.6 Mb region on SSC2 is associated with antibody response to classical swine fever vaccination in a mixed pig population. Anim Biotechnol 33:1128-1133, 2022. Pubmed reference: 33451274. DOI: 10.1080/10495398.2021.1873145.|
|Tu, C.F., Chuang, C.K., Yang, T.S. :|
|The application of new breeding technology based on gene editing in pig industry - A review. Anim Biosci 35:791-803, 2022. Pubmed reference: 34991204. DOI: 10.5713/ab.21.0390.|
|2021||Zhang, J., Khazalwa, E.M., Abkallo, H.M., Zhou, Y., Nie, X., Ruan, J., Zhao, C., Wang, J., Xu, J., Li, X., Zhao, S., Zuo, E., Steinaa, L., Xie, S. :|
|The advancements, challenges, and future implications of the CRISPR/Cas9 system in swine research. J Genet Genomics 48:347-360, 2021. Pubmed reference: 34144928. DOI: 10.1016/j.jgg.2021.03.015.|
|2020||Xie, Z., Jiao, H., Xiao, H., Jiang, Y., Liu, Z., Qi, C., Zhao, D., Jiao, S., Yu, T., Tang, X., Pang, D., Ouyang, H. :|
|Generation of pRSAD2 gene knock-in pig via CRISPR/Cas9 technology. Antiviral Res 174:104696, 2020. Pubmed reference: 31862502. DOI: 10.1016/j.antiviral.2019.104696.|
|2018||Xie, Z., Pang, D., Yuan, H., Jiao, H., Lu, C., Wang, K., Yang, Q., Li, M., Chen, X., Yu, T., Chen, X., Dai, Z., Peng, Y., Tang, X., Li, Z., Wang, T., Guo, H., Li, L., Tu, C., Lai, L., Ouyang, H. :|
|Genetically modified pigs are protected from classical swine fever virus. PLoS Pathog 14:e1007193, 2018. Pubmed reference: 30543715. DOI: 10.1371/journal.ppat.1007193.|
- Created by Imke Tammen2 on 25 Jun 2021
- Changed by Imke Tammen2 on 25 Jun 2021